Clinical trial
Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
NCT01447862 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- May 31, 2015
- Enrollment
- 101 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.